Brevital Sodium Recall: A Hospital Anesthesia Drug Had Particles That Could Cause Blood Clots
This article contains affiliate links. If you purchase through one of these links, we may earn a commission at no extra cost to you. We only recommend products we believe in based on our own research and testing.
If you or your child has an upcoming surgery, or recently had one, there’s a hospital drug recall worth knowing about, even though it never touches your own medicine cabinet.
Par Health has recalled two lots of Brevital Sodium, an anesthesia drug used in hospitals, after finding tiny particles of cellulose inside some vials.
This isn’t a product you buy. It’s an IV anesthesia drug hospitals use to sedate patients before procedures. But knowing it exists can help you ask the right questions if you or a family member is heading into surgery.
What Was Recalled
Par Health, based in Rochester, Michigan, is recalling two lots of Brevital Sodium 500 mg/vial (methohexital sodium for injection, USP, CIV).
The affected lots are:
- Lot 86930, expiring February 2028.
- Lot 88623, expiring April 2028.
Brevital Sodium is an ultra-short-acting barbiturate anesthetic. Hospitals use it to put patients under for surgery or sedation, giving it intravenously to adults and by injection to children before a procedure.
The recalled product shipped to wholesalers and hospitals nationwide between July 2025 and May 2026, according to the FDA notice.
Why It Was Recalled
Par Health found particulate matter identified as cellulose inside vials from these two lots.
That matters because this drug is injected directly into a patient’s bloodstream. The company says administering contaminated product carries a reasonable chance of serious harm, including blood clots in the lungs (pulmonary emboli), blockages in other blood vessels that can damage tissue, and vein inflammation that can lead to clotting.
As of the recall announcement, Par Health says it has not received any reports of patients being harmed by the affected lots.
The FDA posted this recall notice on October 9, 2026, after Par Health’s company announcement the day before.
What Hospitals and Pharmacies Should Do
This recall is addressed to the people who handle the drug, not to patients directly, since Brevital Sodium is never sold or taken at home.
Hospitals, pharmacies, and wholesalers holding either lot should stop using and distributing it immediately. Par Health is notifying wholesale accounts directly and arranging returns of existing inventory through Inmar, Inc.
Any facility that passed the product along to another location should notify that location as well.
What This Means If You or Your Family Had a Procedure
You cannot check your home for this product, because it’s never dispensed to patients to take with them. There’s no lot number to look for in your bathroom cabinet.
If you or your child had IV sedation or anesthesia for a procedure between July 2025 and May 2026, and you want peace of mind, you can ask your hospital or surgical center whether Brevital Sodium was used and, if so, whether it came from one of the affected lots.
Given that Par Health has received no reports of harm connected to this recall so far, this is a precaution, not a sign that something went wrong during your own procedure. For context, this follows a recent hospital injection recall and another nationwide hospital IV recall, both of which were also hospital-only issues with no home product to check.
Frequently Asked Questions
Is Brevital Sodium something I could have at home?
No. It’s an injectable anesthesia drug given only in hospitals and surgical settings by medical staff. It is not dispensed to patients to take home.
How do I know if I received the recalled lot?
You would need to ask your hospital or surgical provider directly. They can check whether the Brevital Sodium used in your procedure came from lot 86930 or 88623.
What’s the actual danger here?
The company says contaminated vials carry a reasonable probability of causing blood clots in the lungs, blockages in other blood vessels, and vein inflammation that can lead to clotting, if administered.
Has anyone been hurt?
As of the recall announcement, Par Health reports no adverse events tied to these lots.
Where can I read the official recall notice?
You can read the full FDA recall notice here, along with Par Health’s contact information for medical questions.
The Bottom Line
This is a hospital-level recall, not a home product recall, but if you or someone in your family had anesthesia or sedation recently, it’s reasonable to ask your care team about it. Par Health has reported no injuries connected to these lots so far, and hospitals have been notified to stop using the affected vials.
